Different Paths and Potentials to Harm Reduction in Different Welfare States: Drug Consumption Rooms in the United Kingdom, Denmark, and France

Affiliations

¹ Marie Jauffret-Roustide is with the Centre d'Étude des Mouvements Sociaux (Inserm U1276/CNRS UMR 8044/EHESS), Paris, France. Esben Houborg and Vibeke Asmussen Frank are with the Center for Alcohol and Drug Research, Aarhus University, Copenhagen, Denmark. Matthew Southwell is with the European Network of People Who Use Drugs, Bath, UK. Daphné Chronopoulou is with the European Network of People Who Use Drugs, Mykonos, Greece. Jean-Maxence Granier is with Auto-Support des Usagers de Drogues/Self-Support for People Who Use Drugs, Paris, France. Alex Stevens is with the School of Social Policy, Sociology and Social Research, University of Kent, Canterbury, UK. Tim Rhodes is with the London School of Hygiene and Tropical Medicine, London, UK. Marie Jauffret-Roustide is also a Guest Editor of this supplement issue.

Editorial

Marie Jauffret-Roustide et al. Am J Public Health. 2022 Apr.

. 2022 Apr;112(S2):S99-S103.

doi: 10.2105/AJPH.2022.306790.

¹ Marie Jauffret-Roustide is with the Centre d'Étude des Mouvements Sociaux (Inserm U1276/CNRS UMR 8044/EHESS), Paris, France. Esben Houborg and Vibeke Asmussen Frank are with the Center for Alcohol and Drug Research, Aarhus University, Copenhagen, Denmark. Matthew Southwell is with the European Network of People Who Use Drugs, Bath, UK. Daphné Chronopoulou is with the European Network of People Who Use Drugs, Mykonos, Greece. Jean-Maxence Granier is with Auto-Support des Usagers de Drogues/Self-Support for People Who Use Drugs, Paris, France. Alex Stevens is with the School of Social Policy, Sociology and Social Research, University of Kent, Canterbury, UK. Tim Rhodes is with the London School of Hygiene and Tropical Medicine, London, UK. Marie Jauffret-Roustide is also a Guest Editor of this supplement issue.

No abstract available

Comment on

Drug Consumption Rooms: Welfare State and Diversity in Social Acceptance in Denmark and in France.
Houborg E, Jauffret-Roustide M. Houborg E, et al. Am J Public Health. 2022 Apr;112(S2):S159-S165. doi: 10.2105/AJPH.2022.306808. Am J Public Health. 2022. PMID: 35349316 Free PMC article.

1. Rhodes T. The “risk environment”: a framework for understanding and reducing drug-related harm. Int J Drug Policy. 2002;13(2):85–94. doi: 10.1016/S0955-3959(02)00007-5. - DOI
1. Rhodes T. Risk environments and drug harms: a social science for harm reduction approach. Int J Drug Policy. 2009;20(3):193–201. doi: 10.1016/j.drugpo.2008.10.003. - DOI - PubMed
1. Collins AB, Boyd J, Cooper HLF, McNeil R. The intersectional risk environment of people who use drugs. Soc Sci Med. 2019;234:112384. doi: 10.1016/j.socscimed.2019.112384. - DOI - PMC - PubMed
1. Ibragimov U, Young AM, Cooper HLF. Understanding rural risk environments for drug-related harms: progress, challenges, and steps forward. Int J Drug Policy. 2020;85:102926. doi: 10.1016/j.drugpo.2020.102926. - DOI - PMC - PubMed
1. Milloy M-JS, Kerr T, Tyndall M, Montaner J, Wood E. Estimated drug overdose deaths averted by North America’s first medically-supervised safer injection facility. PLoS One. 2008;3(10):e3351. doi: 10.1371/journal.pone.0003351. - DOI - PMC - PubMed